Phase IV Randomized Study of Two Dose Levels of Targetin

Project: Research project

Project Details

Description

Phase IV Randomized Study of Two Dose Levels of Targetin Capsules in Patients with Refractory Cutaneous T-Cell Lymphoma
StatusActive
Effective start/end date3/18/1012/31/20

Funding

  • EISAI MEDICAL RESEARCH INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.